Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gautam Borthakur
New Tool for Monitoring Molecular Response in Chronic Myeloid Leukemia.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
BETP Degradation Simultaneously Targets Acute Myelogenous Leukemia Stem Cells and the Microenvironment
Journal of Clinical Investigation
Medicine
Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Transglutaminase2 Expression in Acute Myeloid Leukemia: Association With Adhesion Molecule Expression and Leukemic Blast Motility
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Long-Term Follow-Up of Lower Dose Dasatinib (50 Mg Daily) as Frontline Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Daily Palonosetron Is Superior to Ondansetron in the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Acute Myelogenous Leukemia
Cancer
Cancer Research
Oncology
Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Cancer
Cancer Research
Oncology
Imatinib Front-Line Therapy Is Safe and Effective in Patients With Chronic Myelogenous Leukemia With Pre-Existing Liver and/or Renal Dysfunction
Cancer
Cancer Research
Oncology
1
2
3
›
